Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PODD

Insulet Corporation

Sep 06 • 04:00PM ET

214.75

Dollar change -1.36
Percentage change -0.63	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO SPY VB IVV VO RSP XLV IHI VUG

Scroll to Statements

Index	S&P 500	P/E	39.00	EPS (ttm)	5.51	Insider Own	0.68%	Shs Outstand	69.91M	Perf Week	4.68%
Market Cap	15.06B	Forward P/E	55.71	EPS next Y	3.85	Insider Trans	-3.52%	Shs Float	69.64M	Perf Month	12.79%
Income	395.30M	PEG	2.62	EPS next Q	0.79	Inst Own	100.86%	Short Float	4.07%	Perf Quarter	11.60%
Sales	1.87B	P/S	8.04	EPS this Y	2.04%	Inst Trans	-0.62%	Short Ratio	3.82	Perf Half Y	22.37%
Book/sh	14.24	P/B	15.08	EPS next Y	28.50%	ROA	15.01%	Short Interest	2.83M	Perf Year	11.04%
Cash/sh	11.71	P/C	18.34	EPS next 5Y	14.90%	ROE	50.93%	52W Range	125.82 - 223.56	Perf YTD	-1.03%
Dividend Est.	-	P/FCF	78.84	EPS past 5Y	122.47%	ROI	16.76%	52W High	-3.94%	Beta	1.18
Dividend TTM	-	Quick Ratio	2.68	Sales past 5Y	24.75%	Gross Margin	69.59%	52W Low	70.68%	ATR (14)	8.61
Dividend Ex-Date	-	Current Ratio	3.56	EPS Y/Y TTM	525.48%	Oper. Margin	14.56%	RSI (14)	64.19	Volatility	4.56% 4.20%
Employees	3000	Debt/Eq	1.40	Sales Y/Y TTM	27.82%	Profit Margin	21.11%	Recom	1.46	Target Price	236.30
Option/Short	Yes / Yes	LT Debt/Eq	1.36	EPS Q/Q	565.31%	Payout	0.00%	Rel Volume	0.76	Prev Close	216.11
Sales Surprise	0.10%	EPS Surprise	359.46%	Sales Q/Q	23.20%	Earnings	Aug 08 AMC	Avg Volume	740.34K	Price	214.75
SMA20	10.11%	SMA50	9.47%	SMA200	13.94%	Trades		Volume	559,602	Change	-0.63%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250
Mar-02-22	Resumed	BofA Securities	Buy	$300
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$320
Feb-02-22	Upgrade	UBS	Neutral → Buy	$325
Jan-31-22	Upgrade	Oppenheimer	Perform → Outperform	$300 → $275
Jul-21-21	Resumed	Cowen	Outperform	$285 → $310
May-25-21	Initiated	Barclays	Overweight	$300
Apr-01-21	Upgrade	SVB Leerink	Mkt Perform → Outperform	$275 → $320

Show Previous Ratings

Today 01:16AM	Insulets (PODD) Sales And Margins Surpassed Expectations (Insider Monkey)
Sep-05-24 07:22PM	Analyst Report: Insulet Corporation (Morningstar Research)
Sep-04-24 05:00PM	S&P 500 Gains and Losses Today: Dollar Tree Stock Tumbles After Earnings Miss (Investopedia)
Aug-30-24 10:35AM	Analyst Report: Insulet Corporation (Morningstar Research)
07:20AM	Why Insulet Stock Was Zooming Higher This Week (Motley Fool)
01:46AM	Loading…
01:46AM	Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares (GuruFocus.com)
Aug-28-24 05:25PM	S&P 500 Gains and Losses Today: Supermicro Stock Plunges on Annual Report Delay (Investopedia) +6.15%
Aug-27-24 05:36PM	S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index (Investopedia) +6.58%
12:48PM	Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More (Investopedia)
11:32AM	This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval (Barrons.com)
10:08AM	Insulets Trang Ly on overcoming clinical inertia in diabetes care (MedTech Dive)
08:23AM	Insulet Omnipod cleared by FDA for type 2 diabetes (Medical Device Network)
Aug-26-24 04:20PM	Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes (Business Wire)
01:37PM	Insulet expands Omnipod 5 pump to people with Type 2 diabetes (MedTech Dive)
Aug-20-24 05:25PM	S&P 500 Gains and Losses Today: Palo Alto Networks Surges After Earnings Beat (Investopedia) -6.87%
05:21PM	Loading…
05:21PM	These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise (Investopedia)
12:11PM	Top Stock Movers Now: Boeing, Lowe's, Netflix, Eli Lilly, and More (Investopedia)
06:00AM	Insulet to Present at Upcoming Investor Conferences (Business Wire)
Aug-16-24 08:57PM	Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now (Insider Monkey)
Aug-14-24 03:00AM	Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia (Business Wire)
Aug-10-24 01:04AM	Decoding Insulet Corp (PODD): A Strategic SWOT Insight (GuruFocus.com)
Aug-09-24 05:34PM	Analyst Report: Insulet Corporation (Morningstar Research) -8.81%
05:31PM	S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat (Investopedia)
05:15PM	Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns (Investopedia)
01:19PM	Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Heres Why. (Barrons.com)
12:49PM	Top Stock Movers Now: Sweetgreen, Intel, Akamai Technologies, and More (Investopedia)
10:48AM	Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst (Benzinga)
09:24AM	Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised (Zacks)
Aug-08-24 08:07PM	Insulet inventory pressures cloud annual revenue forecast raise (Reuters)
05:30PM	Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Loading…
05:15PM	Insulet (PODD) Q2 Earnings Miss Estimates (Zacks)
04:07PM	Insulet: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year (Business Wire)
Aug-07-24 09:02AM	Earnings To Watch: Insulet Corp (PODD) Reports Q2 2024 Result (GuruFocus.com)
Aug-05-24 09:16AM	Unlocking Q2 Potential of Insulet (PODD): Exploring Wall Street Estimates for Key Metrics (Zacks)
Aug-01-24 10:01AM	Insulet (PODD) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-26-24 09:37AM	Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge? (The Wall Street Journal)
06:00AM	Insulet Reports Preliminary Second Quarter 2024 Revenue Results (Business Wire)
Jul-18-24 12:00PM	All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy (Zacks)
Jul-16-24 08:45AM	CereVasc Announces Appointments of New Directors (PR Newswire)
Jul-08-24 06:00AM	Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024 (Business Wire)
Jun-25-24 02:32PM	Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2 (Barrons.com)
Jun-24-24 04:08PM	Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks (Bloomberg)
08:36AM	Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes (Zacks)
08:13AM	Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes (MedTech Dive)
07:13AM	Insulet plans label expansion for Omnipod in type 2 diabetes (Medical Device Network)
Jun-21-24 06:30PM	Insulets SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes (Business Wire)
10:59AM	Insulet (PODD) Faces Increasing Competition (Insider Monkey)
08:33AM	Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System (Zacks)
Jun-20-24 06:05AM	Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands (Business Wire)
06:00AM	Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates (Business Wire)
Jun-19-24 06:02AM	The 3 Best Diabetes Stocks to Buy in June 2024 (InvestorPlace)
Jun-17-24 07:01PM	Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field (GuruFocus.com)
Jun-13-24 09:24AM	Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now? (Zacks)
Jun-11-24 07:00PM	Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD) (GuruFocus.com)
Jun-06-24 06:19AM	7 Stocks That Could Safely 10X by 2030 (InvestorPlace)
May-30-24 09:59AM	PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls (The Fly)
May-28-24 06:00AM	Insulet to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks) -5.68%
May-22-24 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
May-19-24 02:08PM	Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains (InvestorPlace)
May-16-24 07:42AM	Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage (MedTech Dive)
May-14-24 04:47PM	S&P 500 Gains and Losses Today: Paramount Global Sinks as Sony Reconsiders Bid (Investopedia) +6.99%
04:44PM	Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market (Benzinga)
03:58PM	Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday? (Benzinga)
11:19AM	Insulet Shares Rise Despite Blue Orca's Short Position (MT Newswires)
May-13-24 10:48AM	Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised (Zacks)
May-10-24 04:55PM	S&P 500 Gains and Losses Today: Akamai Technologies Tumbles on Weak Guidance (Investopedia) -6.55%
03:25PM	Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:24PM	Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance (GuruFocus.com)
09:43AM	Analyst Report: Insulet Corporation (Morningstar Research)
09:24AM	Raymond James Adjusts Price Target on Insulet to $213 From $218 (MT Newswires)
08:10AM	Wolfe Research Raises Price Target on Insulet to $205 From $200 (MT Newswires)
08:00AM	Canaccord Genuity Adjusts Price Target on Insulet to $234 From $226 (MT Newswires)
07:49AM	Jefferies Raises Price Target on Insulet to $260 From $255 (MT Newswires)
May-09-24 08:57PM	PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:30PM	Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings (Zacks)
04:30PM	Insulet Q1 Earnings, Revenue Rise; 2024 Revenue Growth Boosted (MT Newswires)
04:11PM	Insulet: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year (Business Wire)
10:16AM	Nvidia, Micron and Super Micro among companies that shine in Wall Streets beat-and-raise game (MarketWatch)
May-07-24 06:00AM	Insulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth (Business Wire)
May-06-24 09:16AM	Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
May-02-24 06:15PM	Insulet (PODD) Rises Higher Than Market: Key Facts (Zacks)
09:50AM	Why Insulet (PODD) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-28-24 05:50PM	American Politicians are Selling These 10 Stocks (Insider Monkey)
Apr-26-24 06:15PM	Insulet (PODD) Outperforms Broader Market: What You Need to Know (Zacks)
Apr-24-24 08:42AM	Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect (Zacks)
Apr-15-24 09:45AM	7 Stable Stocks for 50% Returns by Early 2025 (InvestorPlace)
Apr-12-24 12:10PM	Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-10-24 06:15PM	Insulet (PODD) Stock Moves -0.34%: What You Should Know (Zacks)
Apr-03-24 06:00AM	Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Apr-02-24 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Mar-28-24 09:55AM	Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High? (Zacks)
Mar-26-24 05:10AM	32 Countries with the Highest Rates of Diabetes (Insider Monkey)
Mar-21-24 09:17AM	Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside (Barrons.com)
06:40AM	Insulet names Ana Maria Chadwick CFO (MedTech Dive)
Mar-20-24 08:11AM	10 NASDAQ Stocks with Biggest Upside (Insider Monkey)
06:00AM	Insulet Appoints Ana Maria Chadwick as Chief Financial Officer (Business Wire)
Mar-19-24 06:39AM	Should You Hold Doximity (DOCS)? (Insider Monkey)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singh Prem	SVP, Global Operations	Aug 30 '24	Sale	202.27	1,824	368,940	3,656	Sep 03 04:30 PM
Singh Prem	Officer	Aug 30 '24	Proposed Sale	202.27	1,824	368,938		Aug 30 03:22 PM
Chadwick Ana Maria	EVP, CFO & Treasurer	Aug 29 '24	Buy	206.00	100	20,600	13,314	Aug 29 04:17 PM
Field Mark N	SVP & Chief Technology Officer	Aug 28 '24	Sale	203.00	1,387	281,561	11,347	Aug 29 04:14 PM
Field Mark N	Officer	Aug 28 '24	Proposed Sale	203.00	1,387	281,561		Aug 28 04:02 PM
Field Mark N	SVP & Chief Technology Officer	Jun 14 '24	Sale	199.96	1,500	299,940	12,875	Jun 17 04:11 PM
Scannell Timothy J	Director	Jun 10 '24	Sale	190.51	7,000	1,333,570	35,586	Jun 11 04:12 PM
Field Mark N	SVP & Chief Technology Officer	Jun 10 '24	Sale	190.43	2,131	405,806	14,375	Jun 11 04:11 PM
BORIO LUCIANA	Director	Jun 04 '24	Sale	182.58	360	65,729	3,298	Jun 05 04:13 PM
Scannell Timothy J	Director	May 28 '24	Option Exercise	32.33	18,267	590,595	45,886	May 29 04:04 PM
Scannell Timothy J	Director	May 28 '24	Sale	180.90	3,300	596,970	42,586	May 29 04:04 PM
Petrovic Shacey	Director	Feb 28 '24	Option Exercise	92.11	11,609	1,069,305	14,176	Feb 29 04:37 PM
Petrovic Shacey	Director	Feb 28 '24	Sale	162.92	11,609	1,891,338	2,567	Feb 29 04:37 PM
BORIO LUCIANA	Director	Dec 15 '23	Sale	207.08	72	14,910	2,278	Dec 18 04:01 PM
Petrovic Shacey	Director	Nov 13 '23	Option Exercise	81.69	20,000	1,633,733	22,567	Nov 14 04:04 PM
Petrovic Shacey	Director	Nov 13 '23	Sale	164.33	20,000	3,286,600	2,567	Nov 14 04:04 PM
Petrovic Shacey	Director	Nov 13 '23	Sale	165.02	15,000	2,475,300	0	Nov 14 04:04 PM
Singh Prem	SVP, Global Operations	Sep 19 '23	Buy	168.92	1	169	4,032	Sep 21 04:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corporation

Upgrade your FINVIZ experience